Biotech

Career and Jobs

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 20.01.2023.

#biotech
#lifesciences
#biopharma
#NPRM
#noncompete
#LifeSciencesNews
#biospace
#investment
#eicAccelerator
#healthcare

@GENbio shared
On Jan 18, 2023
RT @AlexWestchester: 18January: How does @vijaypande of @a16z say the shift of #biotech and #healthcare to an engineering paradigm will reshape drug development and patient care?Read the first of a 2-part Q&A, my latest for GEN Edge, premium content from @GENbio: https://t.co/lwvShgbBDn
Open
Engineering Biology: a16z’s Vijay Pande Discusses Shift from Bespoke Drugs

Engineering Biology: a16z’s Vijay Pande Discusses Shift from Bespoke Drugs

Andreessen Horowitz's Vijay Pande, PhD, discusses the firm's expansion into engineered biology and healthcare exclusively with GEN Edge.

@biospace shared
On Jan 18, 2023
The U.S. @FTC has issued a Notice of Proposed Rulemaking (#NPRM) that could change the landscape for employer-employee relationships nationwide. https://t.co/uTEycdJQNs #lifesciences #biopharma #noncompete #biospace
Open
FTC Seeks to Ban Non-Competes Nationwide, Singles Out BioPharma

FTC Seeks to Ban Non-Competes Nationwide, Singles Out BioPharma

The FTC issued a Notice of Proposed Rulemaking (NPRM) that could change the landscape for employer-employee relationships nationwide, specifically in the biopharma industry.

@SynBioBeta shared
On Jan 16, 2023
RT @multusmedia: 📢 We’re extremely excited to announce a USD$9.5m #SeriesA #investment round to build a world-first growth media facility and enable the affordable scale-up of #CultivatedMeat Learn more ➡️ https://t.co/2QO4vYOpls @innovateuk #eicAccelerator https://t.co/NzC8yKN39Z
Open
Multus Biotechnology announce a USD$9.5m Series A investment round to build a world first growth media facility

Multus Biotechnology announce a USD$9.5m Series A investment round to build a world first growth media facility

We are excited to announce the close of a USD$9.5m Series A investment round. The funding includes an equity free grant of USD$2.5M from Innovate UK through Europe’s most competitive ...

@Labiotech_eu shared
On Jan 20, 2023
This week's guests are from the Advanced Therapies Congress (Terrapinn); Bionter; C2i Genomics; and BioAlps. 👇🏻 #biotech #lifesciences #news https://t.co/NCjBJszKxv
Open
Beyond Biotech podcast 30: Advanced Therapies Congress, BioAlps, Bionter, C2i Genomics

Beyond Biotech podcast 30: Advanced Therapies Congress, BioAlps, Bionter, C2i Genomics

This week's guests are from the Advanced Therapies Congress (Terrapinn); Bionter; C2i Genomics; and BioAlps.

@pharminews shared
On Jan 17, 2023
TB BLOOD-TEST DEVELOPERS PBD BIOTECH APPOINT DR MARIE ROSKROW AS CHAIR https://t.co/dc3pO9Btnl #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #PharmiwebNews https://t.co/s7DJM9ohCZ
Open
TB BLOOD-TEST DEVELOPERS PBD BIOTECH APPOINT DR MARIE ROSKROW AS CHAIR

TB BLOOD-TEST DEVELOPERS PBD BIOTECH APPOINT DR MARIE ROSKROW AS CHAIR

Tuberculosis disease and deaths increased during the COVID-19 pandemic*. This has created global demand for rapid tests such as Actiphage® (developed by PBD Biotech) to improve diagnosis of ...

@SynBioBeta shared
On Jan 19, 2023
Read more: https://t.co/H61unsRgP4 and sign up for our newsletter at https://t.co/cwcwEWlXti
Open
@broadinstitute shared
On Jan 18, 2023
Broad's @CancerDepMap Consortium, is entering a new phase, with 19 biopharma partners, and accelerating its research into tumor vulnerabilities and identifying key biomarkers. https://t.co/toAusgfVHo https://t.co/CLcfnJu9Cc
Open
Cancer Dependency Map Consortium accelerates research into tumor vulnerabilities

Cancer Dependency Map Consortium accelerates research into tumor vulnerabilities

Academic-industrial collaboration, now with 19 industry members, expands efforts to identify new cancer targets.

@SynBioBeta shared
On Jan 19, 2023
RT @johncumbers: Biology labs today suffer the same problem computers had before the invention of the integrated circuit: - too many parts - each device does only one task - parts don't talk to each other This paradigm-shifting technology could replace traditional labs: https://t.co/HpPEZxdFMJ 1/
Open
Can BiologIC’s Biocomputer Help Bring Biomanufacturing To Space?

Can BiologIC’s Biocomputer Help Bring Biomanufacturing To Space?

BiologIC Technologies, a company out of Cambridge, UK, wants to bring disruptive innovation to biomanufacturing with the world's first biocomputer.